STOCK TITAN

Neil Gagnon discloses 5.9% CareDx (CDNA) ownership in updated 13G

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

CareDx, Inc. (CDNA) received an updated ownership report on its common stock from investment manager Neil Gagnon and related entities. As of the reported date, Gagnon reports beneficial ownership of 3,054,946 shares of CareDx common stock, representing 5.9% of the class.

Within this total, Gagnon Securities LLC reports beneficial ownership of 2,213,827 shares, or 4.3% of the class, and Gagnon Advisors, LLC reports 532,892 shares, or 1.0%. The filing states the securities are not held for the purpose of changing or influencing control of CareDx.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Gagnon Securities LLC
Signature:/s/ Neil Gagnon
Name/Title:Neil Gagnon/Chief Executive Officer
Date:02/12/2026
Gagnon Advisors, LLC
Signature:/s/ Neil Gagnon
Name/Title:Neil Gagnon/Managing Member
Date:02/12/2026
Neil Gagnon
Signature:/s/ Neil Gagnon
Name/Title:Neil Gagnon
Date:02/12/2026

FAQ

What ownership in CareDx (CDNA) does Neil Gagnon report in this Schedule 13G/A?

Neil Gagnon reports beneficial ownership of 3,054,946 shares of CareDx common stock, representing 5.9% of the class. This includes shares over which he has sole and shared voting and dispositive power through accounts and investment entities he manages.

How many CareDx (CDNA) shares does Gagnon Securities LLC beneficially own?

Gagnon Securities LLC reports beneficial ownership of 2,213,827 shares of CareDx common stock, equal to 4.3% of the outstanding class. These shares are held in managed accounts for customers, foundations, partnerships, and trusts to which Gagnon Securities furnishes investment advice.

What stake in CareDx (CDNA) does Gagnon Advisors, LLC disclose?

Gagnon Advisors, LLC reports beneficial ownership of 532,892 shares of CareDx common stock, representing 1.0% of the class. These shares are held by Gagnon Investment Associates, LLC, a private investment fund for which Gagnon Advisors acts as investment manager.

Does the filing state that Neil Gagnon seeks to influence control of CareDx (CDNA)?

No. The certification states the securities were not acquired and are not held for the purpose or with the effect of changing or influencing control of CareDx, and are not held in connection with any such control-related transaction.

What voting and dispositive powers over CareDx (CDNA) shares does Neil Gagnon report?

Neil Gagnon reports sole voting and dispositive power over 177,878 CareDx shares and shared voting power over 2,551,068 shares, with shared dispositive power over 2,877,068 shares, reflecting direct holdings and securities managed through Gagnon Securities and Gagnon Advisors.

Do the managed accounts or funds hold more than 5% of CareDx (CDNA) individually?

The filing states the various accounts and the Gagnon Investment Associates fund have rights to dividends and sale proceeds for their holdings, but to the reporting persons’ knowledge, no individual account’s interest exceeds 5% of the CareDx common stock class.
Caredx

NASDAQ:CDNA

CDNA Rankings

CDNA Latest News

CDNA Latest SEC Filings

CDNA Stock Data

1.01B
49.11M
3.43%
101.7%
12.97%
Diagnostics & Research
Services-medical Laboratories
Link
United States
BRISBANE